Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting.

Santoro F, Pettini E, Kazmin D, Ciabattini A, Fiorino F, Gilfillan GD, Evenroed IM, Andersen P, Pozzi G, Medaglini D.

Front Immunol. 2018 Jun 5;9:1248. doi: 10.3389/fimmu.2018.01248. eCollection 2018.

2.

AS03- and MF59-Adjuvanted Influenza Vaccines in Children.

Wilkins AL, Kazmin D, Napolitani G, Clutterbuck EA, Pulendran B, Siegrist CA, Pollard AJ.

Front Immunol. 2017 Dec 13;8:1760. doi: 10.3389/fimmu.2017.01760. eCollection 2017. Review.

3.

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.

Kazmin D, Nakaya HI, Lee EK, Johnson MJ, van der Most R, van den Berg RA, Ballou WR, Jongert E, Wille-Reece U, Ockenhouse C, Aderem A, Zak DE, Sadoff J, Hendriks J, Wrammert J, Ahmed R, Pulendran B.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2425-2430. doi: 10.1073/pnas.1621489114. Epub 2017 Feb 13.

4.

Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.

Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, Del Giudice G, Rappuoli R, Cerundolo V, Pollard AJ, Pulendran B, Siegrist CA.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1853-8. doi: 10.1073/pnas.1519690113. Epub 2016 Jan 11.

5.

Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways.

Choudhary M, Kazmin D, Hu P, Thomas RS, McDonnell DP, Malek G.

J Pathol. 2015 Jan;235(1):101-12. doi: 10.1002/path.4433. Epub 2014 Oct 10.

6.

Immunity to viruses: learning from successful human vaccines.

Pulendran B, Oh JZ, Nakaya HI, Ravindran R, Kazmin DA.

Immunol Rev. 2013 Sep;255(1):243-55. doi: 10.1111/imr.12099. Review.

7.

Systems biological approaches to measure and understand vaccine immunity in humans.

Li S, Nakaya HI, Kazmin DA, Oh JZ, Pulendran B.

Semin Immunol. 2013 Oct 31;25(3):209-18. doi: 10.1016/j.smim.2013.05.003. Epub 2013 Jun 21. Review.

8.
9.

Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation.

Michalek RD, Gerriets VA, Nichols AG, Inoue M, Kazmin D, Chang CY, Dwyer MA, Nelson ER, Pollizzi KN, Ilkayeva O, Giguere V, Zuercher WJ, Powell JD, Shinohara ML, McDonnell DP, Rathmell JC.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18348-53. doi: 10.1073/pnas.1108856108. Epub 2011 Oct 31.

10.

The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.

Chang CY, Kazmin D, Jasper JS, Kunder R, Zuercher WJ, McDonnell DP.

Cancer Cell. 2011 Oct 18;20(4):500-10. doi: 10.1016/j.ccr.2011.08.023.

11.

Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.

Dwyer MA, Kazmin D, Hu P, McDonnell DP, Malek G.

Mol Endocrinol. 2011 Feb;25(2):360-72. doi: 10.1210/me.2010-0392. Epub 2011 Jan 14.

12.

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.

Kobayashi S, Stice JP, Kazmin D, Wittmann BM, Kimbrel EA, Edwards DP, Chang CY, McDonnell DP.

Mol Endocrinol. 2010 Dec;24(12):2292-302. doi: 10.1210/me.2010-0289. Epub 2010 Oct 27.

13.

WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration.

Dwyer MA, Joseph JD, Wade HE, Eaton ML, Kunder RS, Kazmin D, Chang CY, McDonnell DP.

Cancer Res. 2010 Nov 15;70(22):9298-308. doi: 10.1158/0008-5472.CAN-10-0226. Epub 2010 Sep 24.

14.

Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.

Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS.

Mol Endocrinol. 2010 Feb;24(2):359-69. doi: 10.1210/me.2009-0346. Epub 2009 Dec 23.

15.

Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

DuSell CD, Nelson ER, Wittmann BM, Fretz JA, Kazmin D, Thomas RS, Pike JW, McDonnell DP.

Mol Endocrinol. 2010 Jan;24(1):33-46. doi: 10.1210/me.2009-0339. Epub 2009 Nov 9.

16.

Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, Cui H, Anderson E, Fan D, Dye DA, Deng X, Kazmin D, Chang CY, Willson TM, McDonnell DP.

Chem Biol. 2009 Apr 24;16(4):452-60. doi: 10.1016/j.chembiol.2009.01.016.

17.

Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.

Stein RA, Chang CY, Kazmin DA, Way J, Schroeder T, Wergin M, Dewhirst MW, McDonnell DP.

Cancer Res. 2008 Nov 1;68(21):8805-12. doi: 10.1158/0008-5472.CAN-08-1594.

18.

Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Trizna W, Hammond M, Patterson JR, Thompson SK, Kazmin D, Norris JD, McDonnell DP.

Cancer Res. 2008 Sep 15;68(18):7475-83. doi: 10.1158/0008-5472.CAN-08-1047.

19.

Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs.

Gaillard S, Grasfeder LL, Haeffele CL, Lobenhofer EK, Chu TM, Wolfinger R, Kazmin D, Koves TR, Muoio DM, Chang CY, McDonnell DP.

Mol Cell. 2006 Dec 8;24(5):797-803. doi: 10.1016/j.molcel.2006.10.012.

20.

Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators.

Kazmin D, Prytkova T, Cook CE, Wolfinger R, Chu TM, Beratan D, Norris JD, Chang CY, McDonnell DP.

Mol Endocrinol. 2006 Jun;20(6):1201-17. Epub 2006 Mar 30.

21.
22.

Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion.

Sathya G, Chang CY, Kazmin D, Cook CE, McDonnell DP.

Cancer Res. 2003 Nov 15;63(22):8029-36.

23.

Comparative modeling of the N-terminal domain of the 67kDa laminin-binding protein: implications for putative ribosomal function.

Kazmin DA, Chinenov Y, Larson E, Starkey JR.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):161-6.

PMID:
12480536
24.

Visualization of proteins in acrylamide gels using ultraviolet illumination.

Kazmin D, Edwards RA, Turner RJ, Larson E, Starkey J.

Anal Biochem. 2002 Feb 1;301(1):91-6.

PMID:
11811971
25.

Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.

Kazmin DA, Hoyt TR, Taubner L, Teintze M, Starkey JR.

J Mol Biol. 2000 May 5;298(3):431-45.

PMID:
10772861
26.

Both routes to midwifery training needed.

Kazmin D.

Birth Gaz. 1993 Winter;10(1):4. No abstract available.

PMID:
8156019

Supplemental Content

Loading ...
Support Center